| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2015 | SIGA Siga Technologies Inc | Rose Eric A Md | Chief Executive Officer | Sell | 25,000 | $1.43 | $35,786.00 | -1.7% | |
| Jun 22, 2015 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Chairman | Sell | 74,564 | $32.60 | $2,431,048.00 | -1.3% | |
| Jun 17, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Barris Peter J | 10% Owner | Sell | 111,881 | $16.39 | $1,833,603.34 | -69.6% | |
| Jun 17, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Barrett M James | Director, 10% Owner | Sell | 111,881 | $16.39 | $1,833,603.34 | -69.6% | |
| Jun 17, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Sandell Scott D55 | 10% Owner | Sell | 136,597 | $16.50 | $2,254,420.43 | -73.7% | |
| Jun 17, 2015 | AMPH Amphastar Pharmaceuticals, Inc. | Zhou Rong59 | EVP, Production | Sell | 1,000 | $16.48 | $16,480.00 | -3.7% | |
| Jun 17, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Baskett Forest53 | 10% Owner | Sell | 111,881 | $16.39 | $1,833,603.34 | -69.6% | |
| Jun 17, 2015 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 12,000 | $33.13 | $397,580.00 | -7.1% | |
| Jun 17, 2015 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 12,000 | $33.13 | $397,580.00 | -7.1% | |
| Jun 16, 2015 | SIGA Siga Technologies Inc | Luckshire Daniel J | Executive VP &CFO | Sell | 7,500 | $1.54 | $11,550.00 | -14.1% | |
| Jun 16, 2015 | EGRX Eagle Pharmaceuticals, Inc. | Krill Steven L. | Chief Scientific Officer | Sell | 9,980 | $81.60 | $814,368.00 | -100% | |
| Jun 16, 2015 | EBS Emergent Biosolutions Inc. | Sullivan Louis W62 | Director | Sell | 13,457 | $31.32 | $421,540.52 | -32.1% | |
| Jun 16, 2015 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 1,120 | $14.27 | $15,982.40 | - | |
| Jun 16, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Barrett M James | Director, 10% Owner | Sell | 55,105 | $16.85 | $928,668.03 | -33.0% | |
| Jun 16, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Sandell Scott D55 | 10% Owner | Sell | 95,437 | $16.92 | $1,614,570.16 | -41.1% | |
| Jun 16, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Barris Peter J | 10% Owner | Sell | 55,105 | $16.85 | $928,668.03 | -33.0% | |
| Jun 16, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Baskett Forest53 | 10% Owner | Sell | 111,464 | $16.85 | $1,878,080.48 | -49.9% | |
| Jun 15, 2015 | EBS Emergent Biosolutions Inc. | Havey Adam | EVP, Biodefense Divison | Sell | 36,298 | $31.55 | $1,145,052.60 | -24.2% | |
| Jun 15, 2015 | AMPH Amphastar Pharmaceuticals, Inc. | Zhang Jack Y.45 | CEO &Chief Science Officer | Sell | 45,382 | $16.29 | $739,445.23 | -4.7% | |
| Jun 15, 2015 | PBH Prestige Consumer Healthcare Inc. | Parkinson John | Senior Vp- International | Sell | 16,695 | $44.99 | $751,108.05 | -21.1% | |
| Jun 15, 2015 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Chairman | Sell | 45,436 | $32.18 | $1,462,328.55 | -0.8% | |
| Jun 12, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Schwabe Stefan K.F. | Executive Vice President R&D | Sell | 2,051 | $18.27 | $37,471.77 | -42.3% | |
| Jun 12, 2015 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 20,696 | $14.20 | $293,883.20 | -0.2% | |
| Jun 12, 2015 | AMPH Amphastar Pharmaceuticals, Inc. | Zhang Jack Y.45 | CEO &Chief Science Officer | Sell | 160,495 | $16.23 | $2,605,207.03 | -3.3% | |
| Jun 11, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Schwabe Stefan K.F. | Executive Vice President R&D | Sell | 3,631 | $16.39 | $59,520.81 | -23.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.